Vimarsana
Biggest News Aggregation in the World

Page 3 - Ir Team News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ir Team. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ir Team Today - Breaking & Trending Today

Coherus and Junshi Biosciences Announce Publication of Positive Final Overall Survival Results of JUPITER-02, a Phase 3 Trial Evaluating LOQTORZI™ (toripalimab-tpzi) as Treatment for Nasopharyngeal Carcinoma, in the Journal of the American Medical Association - Vimarsana News

Coherus and Junshi Biosciences Announce Publication of Positive Final Overall Survival Results of JUPITER-02, a Phase 3 Trial Evaluating LOQTORZI™ (toripalimab-tpzi) as Treatment for Nasopharyngeal Carcinoma, in the Journal of the American Medical Association

– Final overall survival analysis of the JUPITER-02 trial shows first-line treatment with LOQTORZI plus chemotherapy significantly prolongs survival in patients with recurrent or metastatic NPC...

Junshi Biosciences Announces Lancet Infectious Diseases - Vimarsana News

Junshi Biosciences Announces Lancet Infectious Diseases

SHANGHAI, China, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading...

Graphic Packaging recognized for investor relations and leadership excellence in Institutional Investor awards - Graphic Packaging International - Vimarsana News

Graphic Packaging recognized for investor relations and leadership excellence in Institutional Investor awards - Graphic Packaging International

Graphic Packaging Holding Company was recognized as one of America's Most Honored Companies by Institutional Investors' 2023-2024 All-America Executive Team awards. To achieve this accolade, the...

Investegate | Company Announcement - Vimarsana News

Investegate | Company Announcement

Investegate announcements from Etalon Group PLC Notification of AGM

Coherus and Junshi Biosciences Announce FDA Approval of - Vimarsana News

Coherus and Junshi Biosciences Announce FDA Approval of

–  LOQTORZI is the first and only FDA-approved treatment for NPC – – Indicated in combination with chemotherapy for 1st line treatment and as monotherapy...